Search

Rainbow lights illuminate Renown’s iconic “LOVE” sculpture, and powerful employee stories shared during Pride Month. Reno, Nev. (June 16, 2020) –In celebration of Pride Month and Reno’s LGBTQ+ communities, Renown’s LOVE sculpture, a one-ton, welded aluminum artwork with letters 10-feet tall and eight-feet wide, will be illuminated by rainbow LED lights throughout the month of June. LOVE is located at Renown Regional Medical Center’s main entrance at 1155 Mill Street in Reno, Nev. and visible to vehicular and pedestrian traffic along the Mill Street and Ryland Street corridors. Dr. Tony Slonim, president and CEO of Renown says, “At Renown, we are proud to support our LGBTQ+ communities. During Pride Month and beyond, we are honored to offer an inclusive, safe environment for our staff and patients—one that celebrates diversity in all its forms. The LOVE sculpture has already brought a bright light into our world, and I look forward to the joy it will bring to everyone who gets to see it in rainbow colors.”    In commemoration of Pride Month, Renown is committed to highlighting some of the LGBTQ+ individuals who make up a portion of its 7,000 employees. Sean Savoy, Renown’s manager of spiritual care, shares how his experiences as a gay man positively affect his career in spiritual healing and the compassion he shows others.     "The foundation of spiritual care is compassion – being with people in need by caring, supporting, and showing empathy, and promoting a sense of well-being,” said Savoy. Being a member of the LGBTQ+ community informs that deep sense of compassion and empathy in a very special and unique way.I have found the intersectionality of my gay and spiritual selves has been a blessing in my life."  Created by artist Laura Kimpton and fabricated by Jeff Schomberg, the LOVE sculpture first appeared at Burning Man in 2019. Thanks to a partnership with non-profit Artown, the sculpture debuted at Renown in April of 2020, and since served as a symbol of hope and determination for hospital staff, patients and community members amid the COVID-19 pandemic. Generous donors and the Renown Health Foundation funded the sculpture’s instillation.   ###   About Renown Health  Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org. Media Contact: Public Relations M: 775-691-7308 E: news@renown.org

Read More About Renown Celebrates Pride Month and LGBTQ+ Communities with Love

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

Funds used to support those addressing demographic diversity and Social Determinants of Health to improve the health of our community. Renown Health, in keeping with its mission, vision and values and the organization’s long-standing commitment to addressing the social determinants of health, announced today it will make available up to $20,000 in fiscal year 2020 to fund projects and organizations aiming to increase the presence and participation of women, racial and ethnic minorities, LBGTQ+ people, people with disabilities, people of low socioeconomic status, and other underrepresented groups. Renown Health strongly prefers proposals that convincingly demonstrate their potential to improve the health and wellness of northern Nevadans. The organization wishes to express its interest in supporting programs that enhance collaboration, health literacy and communication, and enhance cultural competency. “Improving the health of our community is the foundation of our work. Our mission, vision and values are the essence of what makes us Renown. We are committed to fostering an environment of diversity, inclusion and cultural competence where all are appreciated, fully engaged and motivated to make a genuine, positive difference in the health and well-being of the people and communities we serve,” said Tony Slonim, MD, DrPH, Renown’s President & CEO. As the Kaiser Family Foundation noted in recent research: “Researchers found that social factors, including education, racial segregation, social supports, and poverty accounted for over a third of total deaths in the United States in a year.” https://www.ajmc.com/contributor/sophia- bernazzani/2016/05/the-importance-of-considering-the-social-determinants-of-health# Annie Zucker, manager of Community Impact at Renown adds, “Social Determinants of Health have a major impact on health outcomes—especially for the most vulnerable populations. I am proud that Renown, as a not-for-profit healthcare organization, considers social determinants of health to enable more compassionate and comprehensive healthcare for the patients and families we serve.” According to the CDC, it has been well-established that poverty inhibits access to healthy foods and safe neighborhoods, and that higher levels of education influence better health. The impact of such factors on health is defined by Healthy People 2020 as social determinants of health: “Social determinants of health are conditions in the environments in which people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.” When resources are available to overcome negative social determinants of health, they can have a significant impact on improving population health outcomes. “Through diversity, inclusiveness and cultural competence we are able to better understand and respond to the health needs of our communities. We are committed to continually cultivating an environment of cultural inclusiveness. When you have a culture that acknowledges and engages everyone, the opportunities for personal growth and organizational effectiveness are limitless,” said Hector Boirie, MBA, Chief Strategy Officer. “Renown Health provides access to care with dignity and respect for all. We recognize and respect every human being, regardless of race, creed, gender, age, handicap, national origin or ability to pay. We give competent, considerate and respectful care in a safe setting that fosters a person’s comfort and dignity and is free from all forms of abuse and harassment, including gender identity or gender expression,” says Melinda Mendoza, BSN, JD, CPC, CHC, CHPC, Chief Compliance Officer. “This is a Renown Health patient right and we are proud of our organizational commitment.” Renown Health is also an Equal Opportunity employer. All qualified applicants receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, marital status, national origin, ancestry, age, genetic information, disability, or protected veteran status. “I am so pleased to serve as Renown’s Chief Financial Officer. Less than 13% of the CFOs in the US are women. How proud I am to help lead an organization that focuses on attracting talent based on individual competency and kindness, rather than gender, race, religion or sexual orientation,” says Ann Beck. Renown Health strongly prefers proposals totaling approximately $2,500 or less as they anticipate funding 8 organizations. Renown Health has made this additional funding available for fiscal year 2020. It normally funds projects for only 6 months at a time, and Renown welcomes applications for renewal funding in subsequent years. All non-profit 501c3 organizations with offices serving residents of northern Nevada are invited to submit proposals by Thursday, June 25 2020. Renown Health will review proposals and make funding decisions by Monday, June 29, 2020. Renown Health will disburse grant funds by Tuesday, June 30, 2020. As non-profit hospitals, Renown must meet community benefit requirements to qualify for tax- exempt status, this includes funding programs that respond to public health needs and improve overall community health. To submit a ‘Renown supports Diversity & Inclusivity grant proposal,’ fill out the grant proposal submission form. For questions, contact Annie Zucker, manager of Community Impact at azucker@renown.org.     About Renown Health Renown Health is an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, marital status, national origin, ancestry, age, genetic information, disability, or protected veteran status. Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, Renown Children’s Hospital, Renown Rehabilitation Hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Health Awards Grants to Area Organizations Addressing Diversity and Inclusiveness

The “LOVE” sculpture, a one-ton, welded aluminum artwork with letters 10-feet tall and eight-feet wide, will find a temporary home at Renown Regional Medical Center’s main entrance at 1155 Mill Street in Reno, Nevada. Debuting at Burning Man in 2019, the free-standing structure is wired for illumination, has weighted steel base plates for anchorage and will be visible to vehicular and pedestrian traffic along the Mill Street and Ryland Street corridors.  “The overall footprint of the sculpture is 40-feet long by 4-feet deep,” says artist Jeff Schomberg, who has collaborated with artist/designer Laura Kimpton, to create 18 letter-based sculptures— including the popular “BELIEVE” piece at Civic Center Plaza in downtown Reno and the “HOME” sculpture for the Reno Aces at Greater Nevada Field. Each letter in the “LOVE” sculpture took Schomberg three to four weeks to build, and the piece takes on an added dimension when illuminated. “The sculpture is lit from within with color changing LED lights. The combination of the LEDs and the aluminum produce(s) a unique look at night,” Schomberg states.  Artist-designer Laura Kimpton, who is dyslexic, says creating monumental word art has been a powerful form of healing and expression. “I can’t tell you how beautiful it is that people will be able to see this work of art at the hospital, contemplate it and be inspired by it,” Kimpton emphasizes. For Artown, inspiring community through the arts is paramount—especially at this moment. “Artown is extremely honored to be able to provide comfort through our partnership with Renown and this incredible work of art by Laura Kimpton and Jeff Schomberg,” says Artown Executive Director Beth Macmillan. “This piece of art and the message of love during these uncertain times, promises to help enlighten, engage and heal the spirits of patients, physicians, nurses and employees at Renown who are fighting the good fight. People passing by the hospital will be warmed and inspired by the art and this one word, LOVE! Now, more than ever, the power of art will provide something beautiful to focus on and restore our confidence.” Providing comfort is in alignment with the non-profit healthcare provider’s mission “to make a genuine difference in the health and well-being of the people and communities we serve…” and is in-step with Renown’s awareness that “during a patient’s most difficult moments, art can be a source of inspiration, comfort and strength.”  Dr. Tony Slonim, president and CEO of Renown says, “I have so much respect for artists like Laura and Jeff, and the way they connect with people through their art. Creating and installing this LOVE sculpture is an act of love they are doing for others. Caring for others and their emotions is also an art. I am inspired by the many passionate caregivers today practicing the art of medicine with patients within the walls of our hospitals, practices and homes. I know this work of art will inspire them. My appreciation goes out to all who helped bring this LOVE sculpture and bright light into our world. Art has been an inspiration to me for a long time and I hope that its beauty helps to bring inspiration and comfort to everyone who gets a chance to see it.”  Members of the media are invited to attend the inaugural lighting of the LOVE sculpture, taking place on Thursday, April 16 at 8 p.m. at the artwork’s new, temporary location at Renown. Due to social distancing, the lighting will NOT be open to the public, however, a live stream of the event will be available through Renown’s Facebook page. In an effort to shine a light on our healthcare workers, several area businesses and neighborhoods are lighting up in conjunction with the LOVE sculpture lighting. Individuals are invited to do the same by placing an enclosed candle or light outside their home.  The installation of the “LOVE” sculpture was funded by generous donors and the Renown Health Foundation. The sculpture will be on display from April 16-July 16 at Renown’s Regional Medical Center, located at 1155 Mill Street, Reno.   About Artown Artown is a non-profit organization whose mission is to strengthen Reno’s arts industry, foster its civic identity and enhance its national image, thereby creating a climate for the cultural and economic rebirth of our region. The month-long summer arts festival features approximately 500 events produced by more than 150 artists, cultural organizations and businesses in locations citywide. For more information, go to artown.org.  About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Artown Partners with Renown to Bring "Love" Sculpture on Mill St.

Renown Health Foundation announced today a special delivery from Sarah Carmona Zink and her Dreams Foundation, donating hundreds of pajamas, receiving blankets, beanie caps, nursing pillows and more, as well as a check for $10,500 for the neonatal intensive care unit (NICU) at Renown Children’s Hospital. Please see visuals to accompany this story here.  For the past three years, Carmona Zink and the Dreams Foundation have staged a fundraisingand baby item drive to give back to the NICU that took care of Carmona Zink’s son, Howie, during a difficult time for the family.  “Our NICU drive is inspired by Howie, who just turned 4,” said Carmona Zink. “Hespent about a month in Renown’s NICU because he was born withgastroschisis, a condition where his intestines formed on the outside of his body.During Howie’s stay, the NICU staff was an extension of our family and cared so deeply for all of us. Our goal through this drive has always been to give back to those who gave so much to us, as well as provide a sense of normalcy to parents with babies in the NICU.During these unprecedented times, providing comfort and relief to parents is more important than ever.” “As a pediatric intensive care physician, who is also a dad, and a new grandfather, I thank Sarah Carmona Zink, her family and the Dreams Foundation for their incredible generosity and compassion. Through the years, Sarah has done so much to support the Renown Children’s Hospital NICU team and other NICU parents- she does so with such joy and enthusiasm, and we are incredibly grateful to her for all that she does,” said Tony Slonim, MD, D.Ph., Renown’s President & CEO. Through this year’s donation drive, Carmona Zink collected the following items for Renown’s NICU:  50 nursing pillows 180 hand-knitted baby beanies 532 pairs of pajamas 682 receiving blankets 8 sleep sacks 473 scent pads, which parents keep on their skin and then leave with their baby so he/she can be comforted by their parents’ scent Books for siblings to read while visiting Miscellaneous items such as pumping storage bottles, bibs, baby hand covers, newborn socks, mobiles, and nursing pillow covers $10,500 monetary donation from the Dreams Foundation   Dr. Max Coppes, Physician-in-Chief of Renown Children’s Hospitaland Larry Duncan, Administrator of Renown Children’s Hospital add, “We are truly blessed with the support for the very smallest residents of Renown Children’s Hospital, some weighing less than a pound! Sarah and her family inspire us to remain devoted to the children we serve, knowing that the community is committed to our Children’s Hospital.” “We look forward to this donation drive every year,” said Renown NICU nurse Jessica Bakke. “The work Sarah and her team do to collect these itemsis very meaningful to all of us. We don’t always have funds to purchase extra items like clothing, blankets and nursing pillows, so everything we receive through this drive makes a differencefor our babies and their families. It is a wonderful gift to be able to offer fresh clothing and other much-needed items to help these parents.”     Greg Walaitis, Chief Development Officer for Renown says, “We are extremely grateful to Sarah and the Dreams Foundation for their generous donation to our NICU. Donations like these help ensure we have plenty of items on hand when our babies and their families need them. This donation allows parents with babies in our NICU to focus solely ontheir baby’s health, rather than material needs that may come up along the way. It is an honor to be the recipient of such an amazing act of kindness for the third year in a row.”     Founded in 2012, Dreams Foundation is a non-profit created to meet the unmet dreams and aspirations of individuals, families, neighborhood churches, people-serving agencies and organizations, recognized charities, boys and girls clubs, and youth sports programs in communities. To learn more, visit dreamsfoundationinc.com.  Ways to Support the Miracles Made Possible at Renown Children’s Hospital Call Renown Health Foundation at 775-982-5545 Make a gift at renown.org/give Mail a check to Renown Health Foundation, 1155 Mill St., O2, Reno, NV 89502 Venmo: @RenownFoundation       About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Dreams Foundation Makes $10,500 Donation Benefiting NICU Babies

Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.

Read More About Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease